105 related articles for article (PubMed ID: 8769635)
1. The role of antibody in the treatment of acute herpes simplex virus disease and in the pathogenesis of latency in newborn guinea pigs.
Tenser RB
J Infect Dis; 1996 Sep; 174(3):667-8. PubMed ID: 8769635
[No Abstract] [Full Text] [Related]
2. Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivation.
Fraser NW; Valyi-Nagy T
Microb Pathog; 1993 Aug; 15(2):83-91. PubMed ID: 8255209
[No Abstract] [Full Text] [Related]
3. The continuing problem of herpes simplex virus persistence.
Rajcáni J; Szántó J
Acta Virol; 1983 Sep; 27(5):442-50. PubMed ID: 6139950
[TBL] [Abstract][Full Text] [Related]
4. Effect of antibody alone and combined with acyclovir on neonatal herpes simplex virus infection in guinea pigs.
Bravo FJ; Bourne N; Harrison CJ; Mani C; Stanberry LR; Myers MG; Bernstein DI
J Infect Dis; 1996 Jan; 173(1):1-6. PubMed ID: 8537645
[TBL] [Abstract][Full Text] [Related]
5. Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus.
Zaia JA; Palmer EL; Feorino PM
J Infect Dis; 1975 Dec; 132(6):660-6. PubMed ID: 172562
[TBL] [Abstract][Full Text] [Related]
6. Neonatal herpes simplex virus infection: relapse after initial therapy and transmission from a mother with an asymptomatic genital herpes infection and erythema multiforme.
Brown ZA; Ashley R; Douglas J; Keilly M; Corey L
Pediatr Infect Dis J; 1987 Nov; 6(11):1057-61. PubMed ID: 2827097
[No Abstract] [Full Text] [Related]
7. Regulation of expression of herpes simplex virus (HSV) glycoprotein D in vaccinia recombinants affects their ability to protect from cutaneous HSV-2 disease.
Wachsman M; Aurelian L; Smith CC; Perkus ME; Paoletti E
J Infect Dis; 1989 Apr; 159(4):625-34. PubMed ID: 2538519
[TBL] [Abstract][Full Text] [Related]
8. Antibody to herpes simplex virus (HSV) ICP-35 proteins after HSV challenge of animals immunized with HSV subunit vaccines.
Bernstein DI; Stanberry LR; Kappes JC; Burke RL; Myers MG
J Infect Dis; 1988 Jun; 157(6):1178-86. PubMed ID: 2836519
[TBL] [Abstract][Full Text] [Related]
9. Production of herpes simplex antisera with increased type specificity in guinea pigs by antibody suppression.
Jeansson S; Ericsson H
Proc Soc Exp Biol Med; 1974 Dec; 147(3):788-94. PubMed ID: 4374703
[No Abstract] [Full Text] [Related]
10. Adjuvant effects of imiquimod on a herpes simplex virus type 2 glycoprotein vaccine in guinea pigs.
Bernstein DI; Miller RL; Harrison CJ
J Infect Dis; 1993 Mar; 167(3):731-5. PubMed ID: 8382722
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activities of human monoclonal antibodies to herpes simplex virus.
Fujinaga S; Sugano T; Matsumoto Y; Masuho Y; Mori R
J Infect Dis; 1987 Jan; 155(1):45-53. PubMed ID: 3025308
[TBL] [Abstract][Full Text] [Related]
12. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
Morrison LA; Knipe DM
Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus type 1 ribonucleotide reductase null mutants induce lesions in guinea pigs.
Turk SR; Kik NA; Birch GM; Chiego DJ; Shipman C
Virology; 1989 Dec; 173(2):733-5. PubMed ID: 2556851
[TBL] [Abstract][Full Text] [Related]
14. [The antiviral activity and therapeutic efficacy of hydrophobized monoclonal antibodies against the herpes simplex virus].
Kolomiets AG; Votiakov VI; Vladyko GV; Ovcharenko AV; Kabanov AV; Melik-Nubarov NS; Iaskovets NIu; Malakhova IV; Eremin VF; Moroz AG
Dokl Akad Nauk SSSR; 1991; 317(6):1487-90. PubMed ID: 1654244
[No Abstract] [Full Text] [Related]
15. Herpes simplex virus vaccines as immunotherapeutic agents.
Stanberry LR
Trends Microbiol; 1995 Jun; 3(6):244-7. PubMed ID: 7648034
[TBL] [Abstract][Full Text] [Related]
16. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity in vivo.
Voss LM; David CS; Showalter SD; Paya CV; Leibson PJ
Int Immunol; 1992 Mar; 4(3):417-20. PubMed ID: 1314641
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus hepatitis and related problems.
Dienes HP; Schirmacher P; Weise K; Falke D
Int Rev Exp Pathol; 1994; 35():1-38. PubMed ID: 7860188
[No Abstract] [Full Text] [Related]
18. Sensitization of guinea pigs to herpes simplex virus.
Rogers HW; Scott LV; Patnode RA
J Immunol; 1972 Oct; 109(4):801-7. PubMed ID: 4342290
[No Abstract] [Full Text] [Related]
19. Herpes simplex virus infections in guinea pigs deficient in the fourth component of complement.
Strunk RC; John TJ; Sieber OF
Infect Immun; 1977 Jan; 15(1):165-8. PubMed ID: 188762
[TBL] [Abstract][Full Text] [Related]
20. [Molecular biology of pathogenesis by herpesvirus].
Barrón BL; Vales N
Rev Latinoam Microbiol; 1991; 33(1):77-85. PubMed ID: 1670258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]